Abstract | OBJECTIVES: MATERIAL AND METHODS: Children aged 4-6 years who had experienced an extensive ISR following a 4th dose of DTPa were recruited and randomly assigned to receive either the recommended DTPa or the lower dose dTpa vaccine. Parents recorded local reactions and systemic events for 15 days following vaccination. Immunogenicity was assessed pre and post vaccination by ELISA for diphtheria (D), tetanus (T), pertussis toxin (PT), filamentous haemagglutinin (FHA), and pertactin (PRN). RESULTS: A total of 53 participants were vaccinated. There was a 72% recurrence rate of ISR, with a trend (p=0.055) towards fewer ISR in the dTpa (61.5%) compared with the DTPa group (85.2%). There was no difference in reports of pain or irritability between groups. All participants had seroprotective levels of antibody to D and T and seroresponse to each of the 3 pertussis antigens following vaccination with higher GMCs in DTPa vs dTpa group. There was no increase in antibody avidity observed post vaccination, regardless of vaccine given. CONCLUSION: Recurrence of ISR with the 5th dose of diphtheria, tetanus and pertussis vaccination in children who have previously experienced an extensive ISR is high. Vaccination with a dTpa vaccine may reduce the risk of fifth dose ISR.
|
Authors | Patrick Quinn, Michael Gold, Jenny Royle, Jim Buttery, Peter Richmond, Peter McIntyre, Nick Wood, Su-San Lee, Helen Marshall |
Journal | Vaccine
(Vaccine)
Vol. 29
Issue 25
Pg. 4230-7
(Jun 06 2011)
ISSN: 1873-2518 [Electronic] Netherlands |
PMID | 21497629
(Publication Type: Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2011 Elsevier Ltd. All rights reserved. |
Chemical References |
- Diphtheria-Tetanus-acellular Pertussis Vaccines
|
Topics |
- Child
- Child, Preschool
- Diphtheria-Tetanus-acellular Pertussis Vaccines
(administration & dosage, adverse effects, immunology)
- Female
- Humans
- Immunization, Secondary
(adverse effects, methods)
- Male
- Recurrence
- Skin Diseases
(chemically induced, epidemiology)
- Vaccination
(adverse effects, methods)
|